BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: So WY, Leung PS. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus. Med Res Rev 2016;36:672-704. [PMID: 27031294 DOI: 10.1002/med.21390] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Luo W, Lin X, Wang T, Cai J, Zeng X, Zhu C, Li R, Wang H, Wu X. Identification of a crucial amino acid responsible for the loss of specifying FGFR1–KLB affinity of the iodinated FGF21. J Cell Physiol 2018;234:2500-10. [DOI: 10.1002/jcp.26780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 de Medina P. Deciphering the metabolic secret of longevity through the analysis of metabolic response to stress on long-lived species. Med Hypotheses 2019;122:62-7. [PMID: 30593426 DOI: 10.1016/j.mehy.2018.10.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhao Y, Zhang L, Liang X, Zhang X, Chang J, Shi M, Liu H, Zhou Y, Sun Z, Zhao Y. Pyruvate Upregulates Hepatic FGF21 Expression by Activating PDE and Inhibiting cAMP–Epac–CREB Signaling Pathway. IJMS 2022;23:5490. [DOI: 10.3390/ijms23105490] [Reference Citation Analysis]
4 Zhang J, Weng W, Wang K, Lu X, Cai L, Sun J. The role of FGF21 in type 1 diabetes and its complications. Int J Biol Sci 2018;14:1000-11. [PMID: 29989062 DOI: 10.7150/ijbs.25026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chang HH, Chen PS, Cheng YW, Wang TY, Yang YK, Lu RB. FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate. Int J Neuropsychopharmacol 2018;21:319-24. [PMID: 29618013 DOI: 10.1093/ijnp/pyx093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Palomares B, Ruiz-Pino F, Navarrete C, Velasco I, Sánchez-Garrido MA, Jimenez-Jimenez C, Pavicic C, Vazquez MJ, Appendino G, Bellido ML, Calzado MA, Tena-Sempere M, Muñoz E. VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity. Sci Rep 2018;8:16092. [PMID: 30382123 DOI: 10.1038/s41598-018-34259-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
7 Nicholson T, Church C, Baker DJ, Jones SW. The role of adipokines in skeletal muscle inflammation and insulin sensitivity. J Inflamm (Lond) 2018;15:9. [PMID: 29760587 DOI: 10.1186/s12950-018-0185-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
8 Min X, Weiszmann J, Johnstone S, Wang W, Yu X, Romanow W, Thibault S, Li Y, Wang Z. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions. J Biol Chem 2018;293:14678-88. [PMID: 30068552 DOI: 10.1074/jbc.RA118.004343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
9 McNulty MA, Goupil BA, Albarado DC, Castaño-Martinez T, Ambrosi TH, Puh S, Schulz TJ, Schürmann A, Morrison CD, Laeger T. FGF21, not GCN2, influences bone morphology due to dietary protein restrictions. Bone Rep 2020;12:100241. [PMID: 31921941 DOI: 10.1016/j.bonr.2019.100241] [Reference Citation Analysis]
10 Kokkinos J, Tang S, Rye K, Ong KL. The role of fibroblast growth factor 21 in atherosclerosis. Atherosclerosis 2017;257:259-65. [DOI: 10.1016/j.atherosclerosis.2016.11.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
11 Yuan D, Wu BJ, Henry A, Rye K, Ong KL. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review. Clin Endocrinol 2019;90:47-55. [DOI: 10.1111/cen.13881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
12 Karamzad N, Maleki V, Carson-Chahhoud K, Azizi S, Sahebkar A, Gargari BP. A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre-diabetes. Biofactors 2020;46:21-37. [PMID: 31573736 DOI: 10.1002/biof.1569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Zhang Y, Liu D, Long XX, Fang QC, Jia WP, Li HT. The role of FGF21 in the pathogenesis of cardiovascular disease. Chin Med J (Engl) 2021;134:2931-43. [PMID: 34939977 DOI: 10.1097/CM9.0000000000001890] [Reference Citation Analysis]
14 Xie T, Yin L, Guo D, Zhang Z, Chen Y, Liu B, Wang W, Zheng Y. The potential role of plasma fibroblast growth factor 21 as a diagnostic biomarker for abdominal aortic aneurysm presence and development. Life Sci 2021;274:119346. [PMID: 33713667 DOI: 10.1016/j.lfs.2021.119346] [Reference Citation Analysis]
15 Dong Z, Gao X, Chinchilli VM, Sinha R, Muscat J, Winkels R, Richie JP Jr. Association of dietary sulfur amino acid intake with mortality from diabetes and other causes. Eur J Nutr 2021. [PMID: 34327571 DOI: 10.1007/s00394-021-02641-w] [Reference Citation Analysis]
16 Yin J, Ren W, Chen S, Li Y, Han H, Gao J, Liu G, Wu X, Li T, Woo Kim S, Yin Y. Metabolic Regulation of Methionine Restriction in Diabetes. Mol Nutr Food Res 2018;62:e1700951. [PMID: 29603632 DOI: 10.1002/mnfr.201700951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
17 Zhao L, Wang H, Xie J, Chen Z, Li X, Niu J. Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice. BMC Biotechnol 2017;17:58. [PMID: 28676059 DOI: 10.1186/s12896-017-0368-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Conte M, Sabbatinelli J, Chiariello A, Martucci M, Santoro A, Monti D, Arcaro M, Galimberti D, Scarpini E, Bonfigli AR, Giuliani A, Olivieri F, Franceschi C, Salvioli S. Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging. Geroscience 2021;43:985-1001. [PMID: 33131010 DOI: 10.1007/s11357-020-00287-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Cheng STW, Li SYT, Leung PS. Fibroblast Growth Factor 21 Stimulates Pancreatic Islet Autophagy via Inhibition of AMPK-mTOR Signaling. Int J Mol Sci 2019;20:E2517. [PMID: 31121855 DOI: 10.3390/ijms20102517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Larson KR, Russo KA, Fang Y, Mohajerani N, Goodson ML, Ryan KK. Sex Differences in the Hormonal and Metabolic Response to Dietary Protein Dilution. Endocrinology 2017;158:3477-87. [DOI: 10.1210/en.2017-00331] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
21 Martínez-Fernández L, González-Muniesa P, Sáinz N, Laiglesia LM, Escoté X, Martínez JA, Moreno-Aliaga MJ. Maresin 1 Regulates Hepatic FGF21 in Diet-Induced Obese Mice and in Cultured Hepatocytes. Mol Nutr Food Res 2019;63:e1900358. [PMID: 31576649 DOI: 10.1002/mnfr.201900358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
22 Mukherjee J, Baranwal A, Schade KN. Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity. Curr Diabetes Rev 2016;12:414-28. [PMID: 27183844 DOI: 10.2174/1573399812666160517115450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
23 Yan X, Gou Z, Li Y, Wang Y, Zhu J, Xu G, Zhang Q. Fibroblast growth factor 21 inhibits atherosclerosis in apoE-/- mice by ameliorating Fas-mediated apoptosis. Lipids Health Dis 2018;17:203. [PMID: 30157856 DOI: 10.1186/s12944-018-0846-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
24 Jimenez V, Jambrina C, Casana E, Sacristan V, Muñoz S, Darriba S, Rodó J, Mallol C, Garcia M, León X, Marcó S, Ribera A, Elias I, Casellas A, Grass I, Elias G, Ferré T, Motas S, Franckhauser S, Mulero F, Navarro M, Haurigot V, Ruberte J, Bosch F. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med 2018;10:e8791. [PMID: 29987000 DOI: 10.15252/emmm.201708791] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 25.0] [Reference Citation Analysis]
25 Rang Y, Ma S, Yang J, Liu H, Suzuki K, Liu C. A Low-Protein High-Fat Diet Leads to Loss of Body Weight and White Adipose Tissue Weight via Enhancing Energy Expenditure in Mice. Metabolites 2021;11:301. [PMID: 34064590 DOI: 10.3390/metabo11050301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Deng J, Liu Y, Liu Y, Li W, Nie X. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy. J Inflamm Res 2021;14:5273-90. [PMID: 34703268 DOI: 10.2147/JIR.S334996] [Reference Citation Analysis]
27 Sharma S, Taliyan R. Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes. Pharmacological Research 2016;113:320-6. [DOI: 10.1016/j.phrs.2016.09.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
28 Ekladious I, Colson YL, Grinstaff MW. Polymer–drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov 2019;18:273-94. [DOI: 10.1038/s41573-018-0005-0] [Cited by in Crossref: 242] [Cited by in F6Publishing: 213] [Article Influence: 60.5] [Reference Citation Analysis]
29 Fauste E, Rodrigo S, Rodríguez L, Donis C, García A, Barbas C, Álvarez-millán JJ, Panadero MI, Otero P, Bocos C. FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny. Journal of Functional Foods 2020;64:103676. [DOI: 10.1016/j.jff.2019.103676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Katsiki N, Mantzoros C. Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction? Metabolism 2019;93:iii-v. [PMID: 30659799 DOI: 10.1016/j.metabol.2019.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Lindberger E, Wikström AK, Sundström Poromaa I, Ahlsson F. Maternal Blood-Based Protein Biomarkers in Relation to Abdominal Fat Distribution Measured by Ultrasound in Early Mid-Pregnancy. Reprod Sci 2022. [PMID: 35147910 DOI: 10.1007/s43032-022-00876-4] [Reference Citation Analysis]
32 Goedeke L, Perry RJ, Shulman GI. Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes. Annu Rev Pharmacol Toxicol 2019;59:65-87. [PMID: 30625285 DOI: 10.1146/annurev-pharmtox-010716-104727] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
33 Zhu Y, Li N, Huang M, Chen X, An YA, Li J, Zhao S, Funcke J, Cao J, He Z, Zhu Q, Zhang Z, Wang ZV, Xu L, Williams K, Li C, Grove K, Scherer PE. Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.020] [Reference Citation Analysis]
34 Zhang X, Lv S, Luo Z, Hu Y, Peng X, Lv J, Zhao S, Feng J, Huang G, Wan QL, Liu J, Huang H, Luan B, Wang D, Zhao X, Lin Y, Zhou Q, Zhang ZN, Rong Z. MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo. Nucleic Acids Res 2021;49:4171-85. [PMID: 33751124 DOI: 10.1093/nar/gkab174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Binder U, Skerra A. PASylation®: A versatile technology to extend drug delivery. Current Opinion in Colloid & Interface Science 2017;31:10-7. [DOI: 10.1016/j.cocis.2017.06.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
36 Swain SK, Prusty K. Biomedical applications of acrylic-based nanohydrogels. J Mater Sci 2018;53:2303-25. [DOI: 10.1007/s10853-017-1726-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
37 Yan K, Chen W, Zhu H, Lin G, Pan H, Li N, Wang L, Yang H, Liu M, Gong F. Ileal Transposition Surgery Decreases Fat Mass and Improves Glucose Metabolism in Diabetic GK Rats: Possible Involvement of FGF21. Front Physiol 2018;9:191. [PMID: 29593555 DOI: 10.3389/fphys.2018.00191] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
38 Hu Y, Liu HX, Jena PK, Sheng L, Ali MR, Wan YY. miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction. JHEP Rep 2020;2:100093. [PMID: 32195457 DOI: 10.1016/j.jhepr.2020.100093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
39 Salminen A, Kaarniranta K, Kauppinen A. Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevity. Cellular Signalling 2017;40:10-21. [DOI: 10.1016/j.cellsig.2017.08.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
40 Zhang X, Yang J, Zhong Y, Xu L, Wang O, Huang P, Li C, Qu B, Wang J, Zheng C, Niu M, Yu W. Association of Bone Metabolic Markers With Diabetic Retinopathy and Diabetic Macular Edema in Elderly Chinese Individuals With Type 2 Diabetes Mellitus. Am J Med Sci 2017;354:355-61. [PMID: 29078839 DOI: 10.1016/j.amjms.2017.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
41 Varanko AK, Chilkoti A. Molecular and Materials Engineering for Delivery of Peptide Drugs to Treat Type 2 Diabetes. Adv Healthcare Mater 2019;8:1801509. [DOI: 10.1002/adhm.201801509] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Leung PS. FGF21 activation-mediated islet autophagy in Type 2 diabetes with pharmacotherapeutic potential. Future Med Chem 2019;11:641-3. [PMID: 30920304 DOI: 10.4155/fmc-2018-0491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Zhou K, Chen H, Lin J, Xu H, Wu H, Bao G, Li J, Deng X, Shui X, Gao W, Ding J, Xiao J, Xu H. FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival. Cell Death Dis 2019;10:872. [PMID: 31740658 DOI: 10.1038/s41419-019-2105-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
44 Eder K, Gessner DK, Ringseis R. Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance. J Anim Sci Biotechnol 2021;12:97. [PMID: 34517929 DOI: 10.1186/s40104-021-00621-y] [Reference Citation Analysis]
45 Chen Q, Ma J, Yang X, Li Q, Lin Z, Gong F. SIRT1 Mediates Effects of FGF21 to Ameliorate Cisplatin-Induced Acute Kidney Injury. Front Pharmacol 2020;11:241. [DOI: 10.3389/fphar.2020.00241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Li S, Wang N, Guo X, Li J, Zhang T, Ren G, Li D. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption. Biomedicine & Pharmacotherapy 2018;108:355-66. [DOI: 10.1016/j.biopha.2018.09.078] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
47 Kim JH, Lee GY, Maeng HJ, Kim H, Bae JH, Kim KM, Lim S. Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model. Endocrinol Metab (Seoul) 2021;36:157-70. [PMID: 33677937 DOI: 10.3803/EnM.2020.781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]